NEOPLASMA
Zoznam článkov
Volume 71, 2024, No. 5
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Obsah:
- Demkova, L. - Matuskova, M. - Gercakova, K. - Kozovska, Z. - Smolkova, B. - Kucerova, L. : The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells. (s. 417)
- Zhang, X. - Li, J. - Zhang, Q. : EIF4A3-induced circle RNA_ 0001860 promotes growth, invasion, and immune evasion of gastric cancer cells through the miR-618/HMGA2 axis. (s. 428)
- Guo, D. - Ma, C. - Gu, J. - Zhai, X. - Chen, X. - Ju, G. - Chu, C. - Zhan, X. - Wang, T. - Tan, M. - Xu, D. : Exploring the role of eIF3m in prostate cancer: regulation of c-Myc signaling pathway and therapeutic implications. (s. 442)
- Li, J. - Cheng, X. - Huang, D. - Cui, R. : Six2 regulates the malignant progression and 5-FU resistance of hepatocellular carcinoma through the PI3K/AKT/mTOR pathway and DNMT1/E-cadherin methylation mechanism. (s. 451)
- Huang, Z. - Zhang, W. - Huang, K. - Feng, J. : Determination of serum vitamin D in patients with renal, bladder, and prostate cancer by ultra-performance liquid chromatography-tandem mass spectrometry. (s. 463)
- Shin, E. - Koo, J. S. : Protein level of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in carcinoma of unknown primary. (s. 473)
- Li, X. - Wu, D. - Tang, J. - Wu, Y. : Albumin bound-paclitaxel combined with anlotinib and immunotherapy in the second-line treatment of ES-SCLC: a retrospective cohort study. (s. 482)
- Zhang, F. - Cui, Q. - Du, H. - Lv, X. - Hou, T. - Chen, Y. - Chen, J. - Liu, J. - Yan, J. - Liu, Y. : Comparative investigation among fluorescence in situ hybridization, DNA- and RNA-sequencing on detecting MYC, BCL2, and BCL6 rearrangements in high-grade B-cell lymphomas. (s. 490)
- Ondrušová, M. - Suchanský, M. - Vándor Svidová, S. - Chowaniecová, G. - Mrinakova, B. - Sekerešová, M. - Juskanič, D. - Ondrus, D. - Šenitko, M. : The real-world comparison of non-small cell lung cancer survival outcomes depending on immunotherapy treatment and PD-L1 expression level. (s. 498)
- Ying, X. - Shi, Z. - Shao, R. - You, G. - Song, Z. : Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer. (s. 509)